• Dec

  20

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

  Dec

  27

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

  Jan

  3

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

  Jan

  10

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

• Jan

  17

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

  Jan

  22

  Research in Progress Seminar Series

  12:00 PM - 1:30 PM

  Jan

  24

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

  Jan

  31

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

• Feb

  7

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

  Feb

  14

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

  Feb

  21

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

  Feb

  26

  Research in Progress Seminar Series

  12:00 PM - 1:30 PM

• Feb

  28

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

  Mar

  7

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

  Mar

  14

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

• MGMT Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide. A Pooled Analysis of Four Clinical Trials.

  Hegi ME, Genbrugge E, Gorlia T, Stupp R, Gilbert MR, Chinot OL, Nabors LB, Jones G, van Criekinge W, Straub J, Weller M.

  Clin Cancer Res. 2018 Dec 4. pii: clincanres.3181.2018. doi: 10.1158/1078-0432.CCR-18-3181. [Epub ahead of print]

• Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.

  Nguyen M, Wong YC, Ysselstein D, Severino A, Krainc D.

  Trends Neurosci. 2018 Nov 30. pii: S0166-2236(18)30282-0. doi: 10.1016/j.tins.2018.11.001. [Epub ahead of print] Review.

• Novel Approach to Tracking Mutant Huntingtin in Biosamples.

  Trajkovic K, Krainc D.

  Trends Mol Med. 2018 Dec;24(12):978-981. doi: 10.1016/j.molmed.2018.10.002. Epub 2018 Oct 24.

• Untangling alpha synuclein fibrils by graphene quantum dots.

  Ysselstein D, Krainc D.

  Mov Disord. 2018 Nov;33(11):1673. doi: 10.1002/mds.27511. No abstract available.

• Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis.

  Kristen AV, Ajroud-Driss S, Conceição I, Gorevic P, Kyriakides T, Obici L.

  Neurodegener Dis Manag. 2018 Nov 27. doi: 10.2217/nmt-2018-0033. [Epub ahead of print]

• Electronic Decision support for Improvement of Contemporary Therapy for Stroke Prevention.

  Chaturvedi S, Kelly AG, Prabhakaran S, Saposnik G, Lee L, Malik A, Boerman C, Serlin G, Mantero AM.

  J Stroke Cerebrovasc Dis. 2018 Nov 21. pii: S1052-3057(18)30621-9. doi: 10.1016/j.jstrokecerebrovasdis.2018.10.041. [Epub ahead of print]

• Quality of Life of Family Caregivers of Patients With Cancer in Korçe, Albania.

  Judkins J, Laska I, Paice J, Kumthekar P.

  J Palliat Care. 2018 Nov 22:825859718812432. doi: 10.1177/0825859718812432. [Epub ahead of print]

• Local Application of Autologous Platelet-Rich Fibrin Patch (PRF-P) Suppresses Regulatory T Cell Recruitment in a Murine Glioma Model.

  Panek WK,… Han Y …

  Mol Neurobiol. 2018 Nov 20. doi: 10.1007/s12035-018-1430-0. [Epub ahead of print]

• Combined Numerical and Experimental Investigation of Localized Electroporation-Based Cell Transfection and Sampling.

  Mukherjee P, Nathamgari SSP, Kessler JA, Espinosa HD.

  ACS Nano. 2018 Nov 27. doi: 10.1021/acsnano.8b05473. [Epub ahead of print]

View full list in PubMed